Nuvalent, Inc.

City:

Cambridge, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2024-09-26

Patent Grants:

Last grant date:

2026-05-19

Top Inventors for applications by Nuvalent, Inc.

These are the the leading inventors for applications assigned to Nuvalent, Inc.:

Joshua Courtney HORAN 5 Somerville, MA United States
Xinxing Tang 4 Pudong, China
Matthew D. Shair 3 Lexington, MA United States
Anupong Tangpeerachaikul 3 Cambridge, MA United States

Baudouin Gerard 3 Arlington, MA United States
Henry Efrem Pelish 3 Newton, MA United States
SCOT RICHARD MENTE 3 ARLINGTON, MA United States
Joshua Courtney Horan 2 Cambridge, MA United States

Henry Efrem Pelish 2 Cambridge, MA United States
Jason T. KROPP 2 Westford, MA United States
Matthew D. Shair 2 Cambridge, MA United States
David James PEARSON 2 Derby, United Kingdom

Christopher G. F. COOPER 2 Rehoboth, MA United States
Scot Richard Mente 2 Cambridge, MA United States
Anupong Tangpeerachaikul 2 Quincy, MA United States
Sibao Chen 2 East Greenwich, RI United States

Benjamin Stephen LANE 2 Lynnfield, MA United States
Yuting Sun 1 Wellesley, MA United States
Kristin Lynne Andrews 1 Concort, MA United States
Kristin Lynne Andrews 1 Concord, MA United States

Yuting Sun 1 Houston, TX United States

Recent patent applications by Nuvalent, Inc.

Nuvalent, Inc. based in Cambridge, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-09-26 ✅ Patent 12,630,560 granted on 2026-05-19

US20240317771A1

Chemistry; metallurgy

SOLID FORMS, PHARMACEUTICAL COMPOSITIONS AND PREPARATION OF HETEROAROMATIC MACROCYCLIC ETHER COMPOUNDS

#2 | 2023-04-20 ✅ Patent 12,043,626 granted on 2024-07-23

US20230124705A1

Chemistry; metallurgy

Solid forms, pharmaceutical compositions and preparation of heteroaromatic macrocyclic ether compounds

#3 | 2023-04-06 ✅ Patent 12,054,498 granted on 2024-08-06

US20230107663A1

Chemistry; metallurgy

Heteroaromatic macrocyclic ether chemotherapeutic agents

#4 | 2023-03-09 ✅ Patent 12,275,742 granted on 2025-04-15

US20230076627A1

Chemistry; metallurgy

Heteroaromatic macrocyclic ether chemotherapeutic agents

#5 | 2023-01-03 ✅ Patent 11,542,278 granted on 2023-01-03

US17514877

Chemistry; metallurgy

Heteroaromatic macrocyclic ether chemotherapeutic agents

#6 | 2022-11-17 ✅ Patent 12,037,346 granted on 2024-07-16

US20220363696A1

Chemistry; metallurgy

Amino-substituted heteroaryls for treating cancers with EGFR mutations

#7 | 2022-03-31 ✅ Patent 11,667,649 granted on 2023-06-06

US20220098212A1

Chemistry; metallurgy

Heteroaromatic macrocyclic ether chemotherapeutic agents

Also check out Nuvalent, Inc.'s (Cambridge, United States) applicant profile with 13 patent applications submitted.

AssigneeID:

600118 ⎘